• OncologyTube
    • 0
      • Title
        User LIVE NOW
      • Logo LIVE NOW
        Title
        User
      • Schedule An Interview
        • Schedule A Remote Interview with OncologyTube
    • Home
    • Trending

    • Sign In

    • Audios and Videos
    • Videos
    • Audios

    • Channels

    • Browse Channels

    • Categories

    • Acute Lymphoblastic Leukemia 5648
    • Acute Myelogenous Leukemia 202
    • Bladder Cancer 71
    • Bone Metastases 2
    • Brain Cancer 59
    • Breast Cancer 233
    • Business Management 3
    • Cervical Cancer 6
    • Chronic Lymphocytic Leukemia 192
    • Chronic Myelogenous Leukemia 43
    • Colorectal Cancer 110
    • COVID-19 27
    • Gastrointestinal Cancer 93
    • General 320
    • Head and Neck Cancers 74
    • Hematologic Malignancies 180
    • Hodgkin Lymphoma 28
    • Immunotherapy 155
    • Kidney Cancer 376
    • Liver Cancer 25
    • Lymphoma 180
    • Melanoma and Skin Cancer 57
    • Multiple Myeloma 466
    • Myeloproliferative Disease 20
    • News 148
    • Non-Hodgkin Lymphoma 77
    • Non-Small Cell Lung Cancer 413
    • Other 256
    • Ovarian Cancer 43
    • Pancreatic Cancer 73
    • Patient Resources 28
    • Pediatric Cancer 3
    • Prostate Cancer 225
    • Sickle Cell 21
    • Small Cell Lung Cancer 72
    • Soft Tissue Sarcoma 10
    • Supportive Care 47
    • Testicular Cancer 3
    • Urology 14
    • Uterine Cancer 7

    • About
    • Contact
    Seth Lerner, MD on Option For Treating Upper Tract Urothelial Cancer @bcmhouston Seth Lerner, MD on Option For Treating Upper Tract Urothelial Cancer @bcmhouston
    0:07:14

    Seth Lerner, MD on Option For Treating Upper Tract Urothelial Cancer @bcmhouston

    Seth Lerner, MD of Baylor College of Medicine @bcmhouston discusses the innovative approach option for treating upper tract urothelial cancer.

    ______________

    Treatment of low-grade upper tract urothelial cancer usually involves radical surgery to remove the kidney and ureter, highlighting the need for improved treatments. An international team led by researchers at Baylor College of Medicine reports in the journal The Lancet Oncology that an innovative form of local chemotherapy using a mitomycin-containing reverse thermal gel offers a kidney-sparing treatment option for this rare cancer affecting 6,000 to 8,000 new patients in the United States every year.

    "Urothelial cancer refers to a cancer of the lining of the urinary system. While about 9 of 10 urothelial cancers arise in the bladder (lower tract), a small subset arises in the upper tract, in the lining of the kidney or the ureter, the long, thin tube that connects that kidney to the bladder," said corresponding and senior author Dr. Seth P. Lerner, professor of urology and Beth and Dave Swalm Chair in Urologic Oncology at Baylor.

    Read here: https://www.eurekalert.org/pub_releases/2020-04/bcom-iao042920.php

    33 Views
    9 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Suggested

    Trending

    JAVELIN Study: How Does This Affect Clinicians? JAVELIN Study: How Does This Affect Clinicians?
    0:02:56

    JAVELIN Study: How Does This Affect Clinicians?

    Free
    54 Views
    1 year ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    HCRN GU14-182: Randomized Double-Blind Phase II Study Of Maintenance Pembrolizumab VS Placebo After First-Line Chemotherapy In Patients with mUC.
    00:05:11

    HCRN GU14-182: Randomized Double-Blind Phase II Study Of Maintenance Pembrolizumab VS Placebo After First-Line Chemotherapy In Patients with mUC.

    Free
    37 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    HCRN GU14-182 Questions: OS Is The Endpoint Needed To See To Impact Practice, Phase 3 Study Will Answer Future Questions
    00:01:26

    HCRN GU14-182 Questions: OS Is The Endpoint Needed To See To Impact Practice, Phase 3 Study Will Answer Future Questions

    Free
    62 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    A bladder-sparing approach for muscle-invasive bladder cancer
    00:02:33

    A bladder-sparing approach for muscle-invasive bladder cancer

    Free
    219 Views
    2 years ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    • 1 (current)
    • 2
    • 3
    • 4

    Urology

    Petros Grivas, MD, PhD @SeattleCCA #UrothelialCancer FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carci... Petros Grivas, MD, PhD @SeattleCCA #UrothelialCancer FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carci...
    0:10:47

    Petros Grivas, MD, PhD @SeattleCCA #UrothelialCancer FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carci...

    Free
    679 Views
    5 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers - Abstract 5019 and Abstract 5020 - Abstract 5019 - Shilpa Gupta MD - Cleveland Clinic @CleClinicMD #bladder... Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers - Abstract 5019 and Abstract 5020 - Abstract 5019 - Shilpa Gupta MD - Cleveland Clinic @CleClinicMD #bladder...
    0:03:42

    Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers - Abstract 5019 and Abstract 5020 - Abstract 5019 - Shilpa Gupta MD - Cleveland Clinic @CleClinicMD #bladder...

    Free
    25 Views
    5 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Seth Lerner, MD on Technical Aspects to Delivering the Drug in Urothelial Cancer @bcmhouston Seth Lerner, MD on Technical Aspects to Delivering the Drug in Urothelial Cancer @bcmhouston
    0:02:30

    Seth Lerner, MD on Technical Aspects to Delivering the Drug in Urothelial Cancer @bcmhouston

    Free
    17 Views
    9 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Seth Lerner, MD on Treating Upper Tract Urothelial Cancer and Adverse Event Rates @bcmhouston Seth Lerner, MD on Treating Upper Tract Urothelial Cancer and Adverse Event Rates @bcmhouston
    0:03:42

    Seth Lerner, MD on Treating Upper Tract Urothelial Cancer and Adverse Event Rates @bcmhouston

    Free
    13 Views
    9 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Seth Lerner, MD on Option For Treating Upper Tract Urothelial Cancer @bcmhouston Seth Lerner, MD on Option For Treating Upper Tract Urothelial Cancer @bcmhouston
    0:07:14

    Seth Lerner, MD on Option For Treating Upper Tract Urothelial Cancer @bcmhouston

    Free
    33 Views
    9 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    JAVELIN Study: How Does This Affect Clinicians? JAVELIN Study: How Does This Affect Clinicians?
    0:02:56

    JAVELIN Study: How Does This Affect Clinicians?

    Free
    54 Views
    1 year ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    What happened to patients with progression of disease? What happened to patients with progression of disease?
    0:04:31

    What happened to patients with progression of disease?

    Free
    7 Views
    1 year ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Phase III JAVELIN Study in Urothelial Cancer @tompowles1 Phase III JAVELIN Study in Urothelial Cancer @tompowles1
    0:04:59

    Phase III JAVELIN Study in Urothelial Cancer @tompowles1

    Free
    32 Views
    1 year ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    HCRN GU14-182: Randomized Double-Blind Phase II Study Of Maintenance Pembrolizumab VS Placebo After First-Line Chemotherapy In Patients with mUC.
    00:05:11

    HCRN GU14-182: Randomized Double-Blind Phase II Study Of Maintenance Pembrolizumab VS Placebo After First-Line Chemotherapy In Patients with mUC.

    Free
    37 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    HCRN GU14-182 Questions: OS Is The Endpoint Needed To See To Impact Practice, Phase 3 Study Will Answer Future Questions
    00:01:26

    HCRN GU14-182 Questions: OS Is The Endpoint Needed To See To Impact Practice, Phase 3 Study Will Answer Future Questions

    Free
    62 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    A bladder-sparing approach for muscle-invasive bladder cancer
    00:02:33

    A bladder-sparing approach for muscle-invasive bladder cancer

    Free
    219 Views
    2 years ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Immunotherapy for prostate, bladder and kidney cancer
    00:02:58

    Immunotherapy for prostate, bladder and kidney cancer

    Free
    104 Views
    2 years ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    • 1 (current)
    • 2

    Copyright 2020 Medicus Networks, Inc. 27574 Commerce Center Drive, Suite 236, Temecula, CA 92592